DHCS Janssen & Distributors Settlement Funds Allowable Expenditures

On July 21, 2021, California Attorney General Rob Bonta announced the final settlement agreements with prescription opioid manufacturer Janssen Pharmaceuticals and pharmaceutical distributors McKesson, Cardinal Health, and AmerisourceBergen (the Janssen and Distributors, or J&D Settlement) that will provide substantial funds for the abatement of the opioid epidemic in California. This document is intended to provide guidance for California’s cities and counties (Participating Subdivisions, listed in Appendix 1 of the California Janssen and Distributors Agreements) that receive funds from the J&D settlements. Allowable expenditures must include activities tied to the ending, reduction or lessening the effects of the opioid epidemic in communities and include prevention, intervention, harm reduction, treatment and recovery services.

Source: DHCS